The total value of the global heart pump devices market was USD 2,212.5 million in 2022, and it will rise at a growth rate of above 22.1% during 2023–2030, reaching USD 10,912.6 million by 2030. This can be credited to the increasing cardiovascular illness occurrence, growing elderly populace, and numerous new product introductions by industry players.
 |
| To learn more about this report: https://bit.ly/45kg0Ci |
Worldwide, heart failure is one of the most common issues. It is an intricate clinical disorder characterized by the irregular working of the heart, which leads to unsatisfactory cardiac output. As per the Global Burden of Heart Failure article published by the NCBI in 2023, over 65 million individuals are impacted by this condition globally. An artificial heart pump can temporarily aid in the pumping action of the heart.
On the basis of product, ventricular assist devices cornered the largest share, of approximately 70%, in 2022. This is mainly because of the growing rate of technical improvements in such items by industry players and the unattainability of organ donors. The vital drivers for the category are the increasing patient pool going through heart failure and the long waiting list for operations.
In 2022, North America held the largest revenue share in the industry, of approximately 45%. This can be credited to the increasing demand for technically progressive cardiac support devices because of the growing occurrence of cardiovascular illnesses. As per government statistics, In Canada, heart illness is the second-leading reason for demise after cancer, with around 67,400 persons in the nation dying as a result of such problems in 2020.
Hence, the increasing cardiovascular illness occurrence, growing elderly populace, and numerous new product introductions by industry players are the major factors propelling the market.
